The Oncology Institute Clinical Trials - The Oncology Institute Hit a Milestone of Opening 160 Clinical Trials and Enrolling 1,000 Patients in 8 Years

Arkansas Oncologist Collaborated On Research Of Targeted Breast Cancer Treatment

Pyrexar Medical announces a distribution agreement with Spain's Magna Medic Systems to bring thermal oncology products to the region.

The Oncology Institute was featured on page 21 of the August 18-31, 2015 issue of The Long Beach Business Journal.

Pyrexar Medical, maker of thermal therapy / hyperthermia medical devices, announce the installation of two BSD-2000 Deep Regional Hyperthermia cancer therapy systems to hospitals in Busan and Seoul, South Korea

This August, The Oncology Institute of Hope and Innovation hit a milestone of serving 50,000 patients. As the largest private practice cancer center in California, The Oncology Institute continues to provide extensive services including state-of-the-art infusion centers. The Oncology Institute of Hope and Innovation has grown to having 12 offices in three counties, LA, Orange and San Bernardino.

Local Cancer Center Is the First in Northwest Arkansas to Treat Brain Cancer Patients with Fast and Precise Image-Guided Radiation Therapy Technology

A clinical trial involving Janssen Diagnostics' CELLSEARCH® System has been recognized by the editors of Clinical Cancer Research1 as being among the most significant studies to appear in the journal in its 20 year history.

Highlands Oncology Group Will Welcome a New Physician to Cancer Treatment Center

Northwest Arkansas Oncologists and Neurosurgeons Meet to Discuss Patient Care

PYREXAR HT Hyperthermia products find distribution with HanBeam Technologies
Pyrexar Medical, the makers of PYREXAR HT Hyperthermia-based cancer treatment systems, announced today that it has received orders for the first two units, of a multi-unit contract, for the BSD-2000 Deep Regional Hyperthermia Systems from the distribution group HanBeam Technology.

Stefan Gluck - Vice President, Global Medical Affairs; Breast, Ovarian Cancer, Immunotherapy - Celgene will present at the Cancer Diagnosis & Therapy Congress to be held on 3 - 4 September 2015 in London, UK.

Highlands Oncology Group Physician Will Have New Abstracts Released at International Congress of the Society for Melanoma Research in Zurich.

Highlands Oncology Group Physician Has Released New Abstracts at American Society of Clinical Oncology Meeting

Donna Kris, a licensed esthetician, brings hope and comfort to cancer patients in the Las Vegas area as Nevada's only Certified Oncology Esthetics® skin therapist.

Donna Kris, a licensed esthetician, brings hope and comfort to cancer patients in the Las Vegas area as Nevada's only Certified Oncology Esthetics® skin therapist.

GMR Data forecast that the global cancer drugs market will reach $143.7bn by 2023. Brand new report published today.

Highlands Oncology Group Physician Will Be Published in Cancer Chemotherapy and Pharmacology.

Dr. J. Thaddeus Beck, of Highlands Oncology Group (HOG), has co-authored an investigation of an explicit treatment option for advanced cancer.

Dr. J. Thaddeus Beck, of Highlands Oncology Group (HOG), will be conducting a clinical trial testing treatments for patients with melanoma carrying the NRAS mutation

The CBCD shows how breast cancer research may benefit from new theory

The Larvol Group, LLC, announced today that it will launch its pharmaceutical CI platform, Larvol DeltaTM at the upcoming Pharma CI Conference on September 11th and 12th in Parsippany, New Jersey.

Erika Pelzer has 10+ years of project management, operations, clinical trials and operational system development experience with UW Medicine, Group Health Research Institute and the University of Massachusetts.

Anaheim, CA 9/16/2011 - Dr. Daniel Jae Kim, along with the outstanding oncologists and hematologists from The Oncology Institute of Hope and Innovation, are celebrating 14 months of success at their Anaheim center.

Jeffrey S. Weber, MD, PhD, of the H. Lee Moffitt Cancer Center leads a 1-day conference to provide clinicians with an update on the science of melanoma, pertinent clinical trial information, investigational agents, and their unusual adverse effects.

Relying on his vast experience in the medical fields of oncology and internal medicine, Dr. Jerry M. Foster will offer nationwide medical consultation for both personal and medico-legal review.

Downey, CA 6/10/2011 - The Oncology Institute of Hope and Innovation, the leader in providing state-of-the-art medical care and comprehensive cancer treatment announced the upcoming addition of Dr. Alexander Gaitanis as part of an expansion of thei

Veeda Oncology, a full service Oncology CRO with headquarters in Columbus, Ohio, has launched a valued new service line as part of its Site Management Services (SMO), Virtual Research Management (VRM), for community-based oncology practices.

Today marks a major advance in the fight against skin cancer, as the U.S. Food and Drug Administration (FDA) approved a new immune-based therapy for the treatment of melanoma, the leading cause of death from skin cancer.

IMER, an oncology continuing education company, will offer a free live webcast on advanced melanoma. This unique event is part of the 6 symposia series IMER will offer during the ONS 36th Annual Congress in Boston.

Glendale, CA 2/8/2011 - The Oncology Institute of Hope and Innovation, the leader in providing state-of-the-art medical care and comprehensive cancer treatment has continued to grow its reach within the Southern California community with a new pres

La Mirada, CA 1/14/2011 - The Oncology Institute of Hope and Innovation, the leader in providing state-of-the-art medical care and comprehensive cancer treatment announced the addition of Dr. Rehana Baqai as part of an expansion into La Mirada.

CROS DE will represent the CROS NT Group at the event in Munich which will discuss challenges and technological strategies for clinical trials in oncology.

Jeremy Barton, VP of Oncology at Biogen Idec will be the keynote presenter on "Targeted Drug Delivery: How Far from the Bulls Eye?" at GTCbio's Cancer Drugs Research & Development Conference in San Diego, CA

Water-Jel Technologies, a world leader in advanced emergency burn care products, has announced the launch of its new breakthrough skincare program for radiation burn care called Radiaderm™ Advanced Skincare System with Lactokine™.

Bentec Medical Inc. (www.bentecmed.com) has introduced a new product called the Bentec Dilator to its line of medical manufacturing tools that is designed for interventional procedures. The thermoplastic Bentec Dilator is designed for percutaneous in

DURHAM, NC (August 3, 2010)  The Board of Directors of the Society for Translational Oncology (STO), after an extensive search, is pleased to name Ms Gabriella (Gabby) Cruze, CCMEP, as its inaugural Executive Director.

The Oncology Institute of Hope and Innovation, the leader in providing state-of-the-art medical care and comprehensive cancer treatment recently announced the opening of it's new Anaheim facility and the appointment of three new physicians.

Abviva announces a plan to return to return to the OTC Bulletin Board and a shareholder awareness program.

Apex Drugs & Intermediates Limited, hyderabad is pleased to announce the launch of its newly designed official website